January 19, 2012
Takeyuki Sato, Associate Center Director, PMDA As part of its effort to strengthen its consultation services, the Pharmaceutical and Medical Devices Agency (PMDA) will expand the functions of its pharmacogenomics (PGx) and biomarker (BM) consultation system starting next fiscal year...read more